- 同花顺特色产品
- 〈高级诊股〉 全方位深度分析，提供明确投资建议
- 短期趋势：
该股处于空头行情中，可能有短期反弹。
- 中期趋势：
有加速下跌的趋势。
- 长期趋势：
已有72家主力机构披露2025-06-30报告期持股数据，持仓量总计11.28亿股，占流通A股65.73%
- 波段诊断：
-
技术面诊股
诊断结果：2.6技术面打败了6%的股票
技术面评分前10的股票
近期的平均成本为5.62元。空头行情中，并且有加速下跌的趋势。
平均成本
近期的平均成本为5.62元。
[{"text":"\u5e73\u5747\u6210\u672c","value":"5.62","date":1765358006,"color":"0x9f0ba1"}]
市场表现
过去10个交易日，该股走势明显跑输大盘，接近行业平均水平。
[{"date":"2025.12.11","stock":"-1.24","trade":"-0.87","ind":"-0.70"},{"date":"2025.12.10","stock":"-0.70","trade":"-0.07","ind":"-0.23"},{"date":"2025.12.09","stock":"-1.72","trade":"-1.51","ind":"-0.37"},{"date":"2025.12.08","stock":"-0.85","trade":"0.25","ind":"0.54"},{"date":"2025.12.05","stock":"0.17","trade":"0.10","ind":"0.70"},{"date":"2025.12.04","stock":"-0.68","trade":"-0.40","ind":"-0.06"},{"date":"2025.12.03","stock":"0.17","trade":"-0.45","ind":"-0.51"},{"date":"2025.12.02","stock":"0.17","trade":"-1.08","ind":"-0.42"},{"date":"2025.12.01","stock":"1.03","trade":"0.07","ind":"0.65"},{"date":"2025.11.28","stock":"-0.34","trade":"-0.17","ind":"0.34"},{"date":"2025.11.27","stock":"-0.85","trade":"-0.20","ind":"0.29"},{"date":"2025.11.26","stock":"0.17","trade":"1.10","ind":"-0.15"},{"date":"2025.11.25","stock":"1.74","trade":"2.23","ind":"0.87"},{"date":"2025.11.24","stock":"0.88","trade":"1.45","ind":"0.05"},{"date":"2025.11.21","stock":"-3.71","trade":"-3.83","ind":"-2.45"},{"date":"2025.11.20","stock":"-0.50","trade":"-0.26","ind":"-0.40"},{"date":"2025.11.19","stock":"-1.81","trade":"-1.93","ind":"0.18"},{"date":"2025.11.18","stock":"-1.30","trade":"-1.16","ind":"-0.81"},{"date":"2025.11.17","stock":"-1.28","trade":"-1.58","ind":"-0.46"},{"date":"2025.11.14","stock":"0.32","trade":"0.97","ind":"-0.97"},{"date":"2025.11.13","stock":"0.32","trade":"1.58","ind":"0.73"}]
华北制药,上证指数,化学制药指数
压力支撑
该股压力位为5.62元，支撑位为5.56元。
[{"text":"\u538b\u529b\u4f4d","value":"5.62","date":1765382400,"color":"0x9f0ba1"},{"text":"\u652f\u6491\u4f4d","value":"5.56","date":1765382400,"color":"0x0b52a1"}]
多空趋势
空头行情中，并且有加速下跌的趋势。
macd
kdj
boll
asi
bias
rsi
wr
vr
资金面诊股
诊断结果：1.6资金面打败了3%的股票
主力控盘前10的股票
行业资金
化学制药行业， 近5日资金总体呈流出状态，请投资者谨慎关注该行业的个股。
更新时间：12月11日 20:38
| 机构今日流向(万元) | -1179.95 | 机构5日流向(万元) | -5233.17 |
| 机构10日流向(万元) | -10373.75 | 机构20日流向(万元) | -22433.26 |
机构持仓
2025-06-30 与 2024-12-31 相比，主力机构持仓量减少558.65万股，其中基金净减仓10家，主力净减仓27家，请投资者中长期谨慎为宜。
截止2025-06-30，共72家主力机构（基金62家，一般法人9家，券商1家），持仓量总计112773.27万股，占流通A股65.73%
其中，基金持仓与2024-12-31相比：
增仓：15家 ，增持 403.66万股
减仓：25家 ，减持 339.53万股
新出现在主力名单中：21家 ，持有46.99万股
从主力名单中消失：48家 ，原持有469.91万股
其中，基金持仓与2024-12-31相比：
增仓：15家 ，增持 403.66万股
减仓：25家 ，减持 339.53万股
新出现在主力名单中：21家 ，持有46.99万股
从主力名单中消失：48家 ，原持有469.91万股
消息面诊股
诊断结果：5.5消息面打败了63%的股票
今日有利好新闻的公司
近期该股消息面总体多空平衡，没有较强的利好或利空趋势。
更多>>个股资讯
- 华北制药：12月10日获融资买入627.54万元
2025-12-11 - 冀中能源集团华北制药首个高活制剂生产车间建成投产
2025-12-10 - 首版商保创新药目录发布：阿尔茨海默病新药纳入 肿瘤
2025-12-10 - 华北制药：12月8日获融资买入913.21万元
2025-12-09 - 华北制药：12月5日获融资买入433.33万元
2025-12-06 - 27年联合攻关，爱诺公司喜获国家自然资源科技进步一
2025-12-05 - 华北制药首个高活制剂生产车间建成投产
2025-12-05 - 华北制药：12月4日获融资买入349.70万元
2025-12-05 - 【火热】暴涨196%潜力品种，华北制药发起冲击
2025-12-04 - 爱诺联合攻关项目获自然资源科学技术奖
2025-12-03
消息列表
| 一般消息 | 股东大会 | 临时股东大会 | 2025-11-29 |
| 一般消息 | 高管变动 | 委员会更名 | 2025-11-28 |
| 一般消息 | 分红转增 | 不分配不转增 | 2025-08-14 |
| 一般消息 | 募资投向 | 公司购买资产 | 2025-07-30 |
| 重大利好 | 业绩预告 | 业绩大幅上升 | 2025-07-11 |
| 利好 | 重大事项 | 参股拟上市公司或非上市公司金融机构 | 2025-06-30 |
| 一般消息 | 重大事项 | 关联交易 | 2025-06-12 |
| 一般消息 | 高管变动 | 因连续任职已满六年 | 2025-05-21 |
| 一般消息 | 重大事项 | 公司股东股份解押 | 2025-05-15 |
| 一般消息 | 重大事项 | 关联交易 | 2025-04-24 |
| 利好 | 分红转增 | 10派0.3元(含税) | 2025-03-28 |
| 一般消息 | 重大事项 | 关联交易 | 2025-03-28 |
| 重大利好 | 业绩预告 | 业绩大幅上升 | 2025-01-17 |
| 利好 | 重大事项 | 参股拟上市公司或非上市公司金融机构 | 2024-12-31 |
一年消息统计
| 所有消息 | 重大消息 | 非重大消息 | |
| 利好 | 5条 | 2条 | 3条 |
| 利空 | 0条 | 0条 | 0条 |
行业面诊股
诊断结果：5.2行业面打败了73%的股票
化学制药行业最新资金流向
近10日来该行业走势不明显，明显跑输大盘。最近120个交易日，机构评级以增持为主，认为该行业有一定投资价值。
行业走势
近10日来该行业走势不明显，明显跑输大盘。
[{"date":"2025.12.11","price":"-0.70","value":"-0.87"},{"date":"2025.12.10","price":"-0.23","value":"-0.07"},{"date":"2025.12.09","price":"-0.37","value":"-1.51"},{"date":"2025.12.08","price":"0.54","value":"0.25"},{"date":"2025.12.05","price":"0.70","value":"0.10"},{"date":"2025.12.04","price":"-0.06","value":"-0.40"},{"date":"2025.12.03","price":"-0.51","value":"-0.45"},{"date":"2025.12.02","price":"-0.42","value":"-1.08"},{"date":"2025.12.01","price":"0.65","value":"0.07"},{"date":"2025.11.28","price":"0.34","value":"-0.17"},{"date":"2025.11.27","price":"0.29","value":"-0.20"},{"date":"2025.11.26","price":"-0.15","value":"1.10"},{"date":"2025.11.25","price":"0.87","value":"2.23"},{"date":"2025.11.24","price":"0.05","value":"1.45"},{"date":"2025.11.21","price":"-2.45","value":"-3.83"},{"date":"2025.11.20","price":"-0.40","value":"-0.26"},{"date":"2025.11.19","price":"0.18","value":"-1.93"},{"date":"2025.11.18","price":"-0.81","value":"-1.16"},{"date":"2025.11.17","price":"-0.46","value":"-1.58"},{"date":"2025.11.14","price":"-0.97","value":"0.97"},{"date":"2025.11.13","price":"0.73","value":"1.58"}]
上证指数,化学制药行业
行业排名
| 排名 | 股票名称 | 1月涨跌幅 | 5日涨跌幅 | 评分 |
|---|---|---|---|---|
| 1 | 康芝药业 | 34.24% | 7.90% | 5.2分 |
| 2 | 海南海药 | 29.92% | -1.24% | 4.8分 |
| 3 | 常山药业 | 27.42% | 1.05% | 5.6分 |
| 4 | 悦康药业 | 22.78% | 8.14% | 6.4分 |
| 5 | 海创药业 | 18.31% | 20.63% | 5.9分 |
| 6 | 前沿生物 | 16.78% | 4.07% | 5.7分 |
| 8 | 福元医药 | 8.71% | -0.35% | 5.8分 |
| 10 | 京新药业 | 6.19% | 3.14% | 5.3分 |
| 12 | 圣诺生物 | 4.61% | 0.64% | 5.7分 |
| 14 | 普洛药业 | 3.21% | -1.05% | 5.7分 |
| 16 | 海思科 | 1.71% | -6.65% | 5.4分 |
| 18 | 海欣股份 | 0.43% | -0.42% | 5.7分 |
| 20 | 恒瑞医药 | -0.25% | 3.51% | 6.6分 |
| 22 | 亚虹医药 | -0.69% | -2.05% | 4.8分 |
| 24 | ST诺泰 | -1.00% | 6.49% | 5.6分 |
| 26 | 复星医药 | -1.18% | 5.82% | 6.0分 |
| 28 | 新诺威 | -1.46% | 9.23% | 5.2分 |
| 30 | ST复华 | -2.22% | 1.60% | 4.6分 |
| 32 | 恩华药业 | -3.82% | -1.15% | 5.2分 |
| 34 | 广济药业 | -4.11% | -16.18% | 4.1分 |
| 36 | 新华制药 | -4.60% | -5.60% | 4.3分 |
| 38 | 山河药辅 | -4.81% | -5.21% | 3.8分 |
| 40 | 金陵药业 | -4.97% | -4.32% | 5.2分 |
| 42 | 迪哲医药 | -5.11% | -1.44% | 4.5分 |
| 44 | 福安药业 | -5.29% | -3.86% | 4.9分 |
| 46 | 兴齐眼药 | -5.51% | -3.29% | 5.1分 |
| 48 | 华润双鹤 | -5.69% | -1.64% | 5.0分 |
| 50 | 哈药股份 | -5.79% | -3.76% | 5.1分 |
| 52 | 微芯生物 | -6.10% | 3.66% | 5.6分 |
| 54 | 亿帆医药 | -6.24% | -3.98% | 5.0分 |
| 56 | 博瑞医药 | -6.42% | -1.68% | 5.0分 |
| 58 | 华海药业 | -6.46% | -0.51% | 5.2分 |
| 60 | 丽珠集团 | -6.81% | -2.18% | 4.9分 |
| 62 | 一品红 | -7.03% | -0.75% | 4.5分 |
| 64 | 海森药业 | -7.09% | -4.29% | 4.4分 |
| 66 | 新和成 | -7.29% | -0.33% | 5.4分 |
| 68 | 金石亚药 | -7.51% | -6.89% | 4.1分 |
| 70 | 津药药业 | -7.61% | -5.49% | 4.4分 |
| 72 | 浙江医药 | -7.79% | -0.65% | 5.0分 |
| 74 | 润都股份 | -7.90% | -6.71% | 3.8分 |
| 76 | 华纳药厂 | -8.07% | 2.91% | 5.7分 |
| 78 | 东北制药 | -8.19% | -5.61% | 4.4分 |
| 80 | 丰原药业 | -8.33% | -7.27% | 4.9分 |
| 82 | 西点药业 | -8.58% | -6.74% | 4.3分 |
| 84 | 宣泰医药 | -9.05% | -1.86% | 4.9分 |
| 86 | 多瑞医药 | -9.34% | 3.91% | 4.9分 |
| 88 | 誉衡药业 | -9.59% | -3.42% | 5.1分 |
| 90 | 罗欣药业 | -9.71% | -6.86% | 4.1分 |
| 92 | 百济神州 | -9.84% | -2.00% | 4.7分 |
| 94 | 能特科技 | -10.03% | -0.85% | 5.0分 |
| 96 | 中关村 | -10.29% | -5.97% | 4.7分 |
| 98 | 汉商集团 | -10.31% | -5.44% | 5.1分 |
| 100 | 健友股份 | -10.35% | -3.64% | 4.7分 |
| 102 | ST天圣 | -10.44% | -3.17% | 4.0分 |
| 104 | 小方制药 | -10.46% | -1.56% | 5.1分 |
| 106 | 哈三联 | -10.67% | -7.66% | 3.9分 |
| 108 | 新天地 | -10.79% | -3.43% | 4.2分 |
| 110 | 赛托生物 | -11.02% | -5.16% | 3.9分 |
| 112 | 尔康制药 | -11.36% | -7.63% | 4.1分 |
| 114 | 仟源医药 | -11.39% | -3.00% | 4.8分 |
| 116 | - | -11.60% | 1.38% | 分 |
| 118 | 贝达药业 | -11.67% | 1.56% | 4.8分 |
| 120 | 威尔药业 | -11.81% | -1.83% | 5.4分 |
| 122 | 北陆药业 | -11.90% | -1.86% | 4.8分 |
| 124 | 立方制药 | -12.48% | -0.07% | 5.2分 |
| 126 | 东亚药业 | -12.76% | -4.85% | 4.3分 |
| 128 | - | -13.20% | 2.10% | 分 |
| 130 | 川宁生物 | -13.46% | -4.28% | 4.1分 |
| 132 | 辰欣药业 | -13.71% | -0.28% | 4.5分 |
| 134 | 汇宇制药 | -13.86% | -2.30% | 4.6分 |
| 136 | 溢多利 | -14.19% | -6.89% | 3.9分 |
| 138 | 德展健康 | -14.44% | -3.27% | 3.8分 |
| 140 | 人福医药 | -14.84% | -5.39% | 4.2分 |
| 142 | 亚太药业 | -14.89% | 2.48% | 4.8分 |
| 144 | 南新制药 | -15.62% | -3.99% | 3.5分 |
| 146 | 海辰药业 | -16.20% | -1.59% | 4.1分 |
| 148 | 富祥药业 | -16.57% | 0.90% | 4.6分 |
| 150 | - | -16.89% | 0.32% | 分 |
| 152 | 昂利康 | -17.53% | -4.21% | 4.6分 |
| 154 | 司太立 | -22.98% | -2.26% | 4.7分 |
| 156 | 宏源药业 | -23.75% | -2.40% | 3.8分 |
| 158 | 退市苏吴 | -54.55% | -59.82% | 4.7分 |
行业评级
最近120个交易日，机构评级以增持为主，认为该行业有一定投资价值。
- 综合评级
| 研究机构 | 评级日期 | 最新评级 | 上次评级 |
| 中信证券 | 2012-09-10 | 增持 | 增持 |
| 招商证券 | 2012-09-08 | 增持 | 增持 |
| 航天证券 | 2012-09-06 | 增持 | - |
| 中银国际 | 2012-09-05 | 增持 | - |
| 齐鲁证券 | 2012-09-05 | 增持 | - |
更多>>行业资讯
- 2012-09-13亿利能源股权质押登记
- 2012-09-13太极集团修改《公司章程》
- 2012-09-13人福医药获得国家补助资金
- 2012-09-13常山药业：归还暂时用于补充流动资金的闲置募集资金
- 2012-09-13贵州百灵：公司与济南百诺医药科技开发有限公司签订技
- 2012-09-13振东制药山西省第三建筑工程公司承建山西振东泰盛制药
- 2012-09-13双成药业：战略合作框架协议进展
- 2012-09-13佛慈制药：签订推荐恢复上市、委托代办股份转让协议
- 2012-09-13昊海生科IPO资产被疑是大江股份上市募投项目
- 2012-09-13泰格医药涨势猛 业务有望快速扩张
基本面诊股
[ 截止日期：2025-09-30 ]公司经营
盈利能力：较强，高于行业平均，建议加强关注，两项指标的行业排名分别为 88/219 ， 118/219。
[{"date":"2025-09-30","value":"2.91","vol":"1.46"},{"date":"2025-06-30","value":"2.28","vol":"1.21"},{"date":"2025-03-31","value":"1.06","vol":"-0.17"},{"date":"2024-12-31","value":"2.37","vol":"19.51"},{"date":"2024-09-30","value":"1.92","vol":"4.61"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 净资产收 益率(%) |
2.91 | 2.28 | 1.06 | 2.37 | 1.92 |
| 行业(%) | 1.46 | 1.21 | -0.17 | 19.51 | 4.61 |
该指标值越高，盈利能力越强，行业排名越靠前。
[{"date":"2025-09-30","value":"29.25","vol":"49.47"},{"date":"2025-06-30","value":"29.62","vol":"49.43"},{"date":"2025-03-31","value":"29.44","vol":"49.23"},{"date":"2024-12-31","value":"31.97","vol":"50.77"},{"date":"2024-09-30","value":"30.26","vol":"50.51"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 销售毛利 率(%) |
29.25 | 29.62 | 29.44 | 31.97 | 30.26 |
| 行业(%) | 49.47 | 49.43 | 49.23 | 50.77 | 50.51 |
该指标值越高，盈利能力越强，行业排名越靠前。
成长能力：较强，高于行业平均，建议加强关注，两项指标的行业排名分别为 67/219 ， 24/219。
[{"date":"2025-09-30","value":"-1.00","vol":"141.76"},{"date":"2025-06-30","value":"0.84","vol":"78.53"},{"date":"2025-03-31","value":"0.65","vol":"-0.84"},{"date":"2024-12-31","value":"-2.48","vol":"17.76"},{"date":"2024-09-30","value":"-5.20","vol":"45.69"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 营业收入同 比增长率(%) |
-1.00 | 0.84 | 0.65 | -2.48 | -5.20 |
| 行业(%) | 141.76 | 78.53 | -0.84 | 17.76 | 45.69 |
该指标值越高，成长能力越强，行业排名越靠前。
[{"date":"2025-09-30","value":"54.69","vol":"-5.21"},{"date":"2025-06-30","value":"71.56","vol":"56.29"},{"date":"2025-03-31","value":"216.72","vol":"-21.21"},{"date":"2024-12-31","value":"2496.80","vol":"-20.55"},{"date":"2024-09-30","value":"266.29","vol":"-32.33"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 净利润同比 增长率(%) |
54.69 | 71.56 | 216.72 | 2496.80 | 266.29 |
| 行业(%) | -5.21 | 56.29 | -21.21 | -20.55 | -32.33 |
该指标值越高，成长能力越强，行业排名越靠前。
营运能力：较强，高于行业平均，建议加强关注，两项指标的行业排名分别为 49/219 ， 41/219。
[{"date":"2025-09-30","value":"0.35","vol":"0.31"},{"date":"2025-06-30","value":"0.24","vol":"0.21"},{"date":"2025-03-31","value":"0.12","vol":"0.10"},{"date":"2024-12-31","value":"0.47","vol":"0.43"},{"date":"2024-09-30","value":"0.35","vol":"0.33"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 总资产周 转率(次) |
0.35 | 0.24 | 0.12 | 0.47 | 0.35 |
| 行业(次) | 0.31 | 0.21 | 0.10 | 0.43 | 0.33 |
该指标值越高，营运能力越强，行业排名越靠前。
[{"date":"2025-09-30","value":"2.22","vol":"1.95"},{"date":"2025-06-30","value":"1.54","vol":"1.31"},{"date":"2025-03-31","value":"0.74","vol":"0.67"},{"date":"2024-12-31","value":"2.62","vol":"3.22"},{"date":"2024-09-30","value":"2.08","vol":"2.18"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 存货增长 率(次) |
2.22 | 1.54 | 0.74 | 2.62 | 2.08 |
| 行业(次) | 1.95 | 1.31 | 0.67 | 3.22 | 2.18 |
该指标值越高，营运能力越强，行业排名越靠前。
现金流能力：数据暂时不全，请后续关注
[{"date":"2025-09-30","value":"7.69","vol":"4.36"},{"date":"2025-06-30","value":"12.15","vol":"2.81"},{"date":"2025-03-31","value":"6.34","vol":"-28.76"},{"date":"2024-12-31","value":"7.41","vol":"-371.46"},{"date":"2024-09-30","value":"7.52","vol":"-9.87"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 现金流量净额/营业收入 | 7.69 | 12.15 | 6.34 | 7.41 | 7.52 |
| 行业 | 4.36 | 2.81 | -28.76 | -371.46 | -9.87 |
该指标值越高，现金流能力越强，行业排名越靠前。
[{"date":"2025-09-30","value":"","vol":"0.00"},{"date":"2025-06-30","value":"0.50","vol":"1.72"},{"date":"2025-03-31","value":"","vol":"0.00"},{"date":"2024-12-31","value":"0.90","vol":"1.99"},{"date":"2024-09-30","value":"","vol":"0.00"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 资本支出／折旧和摊销 | - | 0.50 | - | 0.90 | - |
| 行业 | 0.00 | 1.72 | 0.00 | 1.99 | 0.00 |
该指标值越低，现金流能力越强，行业排名越靠前。
短期偿债能力：很强，位居行业前列,建议强烈关注，两项指标的行业排名分别为 98/219 ， 59/219。
[{"date":"2025-09-30","value":"0.67","vol":"3.49"},{"date":"2025-06-30","value":"0.71","vol":"3.67"},{"date":"2025-03-31","value":"0.73","vol":"3.59"},{"date":"2024-12-31","value":"0.75","vol":"3.34"},{"date":"2024-09-30","value":"0.78","vol":"3.66"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 流动比率 |
0.67 | 0.71 | 0.73 | 0.75 | 0.78 |
| 行业 | 3.49 | 3.67 | 3.59 | 3.34 | 3.66 |
该指标值越接近2，短期偿债能力越强，行业排名越靠前。
[{"date":"2025-09-30","value":"0.47","vol":"2.74"},{"date":"2025-06-30","value":"0.49","vol":"2.89"},{"date":"2025-03-31","value":"0.50","vol":"2.81"},{"date":"2024-12-31","value":"0.49","vol":"2.64"},{"date":"2024-09-30","value":"0.52","vol":"2.92"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 速动比率 |
0.47 | 0.49 | 0.50 | 0.49 | 0.52 |
| 行业 | 2.74 | 2.89 | 2.81 | 2.64 | 2.92 |
该指标值越接近1，短期偿债能力越强，行业排名越靠前。
长期偿债能力：较强，高于行业平均，建议加强关注，两项指标的行业排名分别为 67/219 ， 6/219。
[{"date":"2025-09-30","value":"69.01","vol":"33.75"},{"date":"2025-06-30","value":"69.09","vol":"33.79"},{"date":"2025-03-31","value":"69.30","vol":"34.04"},{"date":"2024-12-31","value":"68.91","vol":"34.19"},{"date":"2024-09-30","value":"69.57","vol":"33.02"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 资产负债 率(%) |
69.01 | 69.09 | 69.30 | 68.91 | 69.57 |
| 行业(%) | 33.75 | 33.79 | 34.04 | 34.19 | 33.02 |
该指标值越接近50%，长期偿债能力越强，行业排名越靠前。
[{"date":"2025-09-30","value":"2.70","vol":"0.94"},{"date":"2025-06-30","value":"2.75","vol":"0.88"},{"date":"2025-03-31","value":"2.80","vol":"1.46"},{"date":"2024-12-31","value":"2.75","vol":"0.84"},{"date":"2024-09-30","value":"2.82","vol":"0.73"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 产权比率 (%) |
2.70 | 2.75 | 2.80 | 2.75 | 2.82 |
| 行业(%) | 0.94 | 0.88 | 1.46 | 0.84 | 0.73 |
该指标值越高，长期偿债能力越强，行业排名越靠前。
机构预测
暂时还没有机构预测该股2025年的收益，请投资者后续关注。
[{"date":"2021","yellowRectValue":"0.19","blueLineValue":"","type":""},{"date":"2022","yellowRectValue":"-6.89","blueLineValue":"","type":""},{"date":"2023","yellowRectValue":"0.05","blueLineValue":"","type":""},{"date":"2024","yellowRectValue":"1.27","blueLineValue":"","type":""},{"date":"2025","yellowRectValue":"0.00","blueLineValue":"","type":"YC"}]